Avanza Fonder’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-25,341
Closed -$866K 448
2025
Q1
$866K Buy
+25,341
New +$866K 0.03% 361